Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03461471 · ClinicalTrials.gov registry record · NA

Exercise in All ChemoTherapy

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
168
Enrollment target

NCT03461471: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT03461471 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 168 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03461471, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
168 participants
Enrollment target

Study Summary

Exercise in all Chemotherapy (EnACT) is a study to assess safety, feasibility, and acceptability of an exercise program within chemotherapy. This will be a single group study to capture the effects of an exercise intervention on the average chemotherapy patient and the patients compliance to the study.

Primary Outcome

Feasibility will be obtained if one third of chemotherapy patients actually do the exercise prescribed (one exercise session per week for four weeks).

Interventions

  • BEHAVIORAL Exercise Intervention

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2017-04-01
Est. Completion 2019-03-30
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT03461471 record still lists

NCT03461471 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT03461471 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03461471 about?

NCT03461471 is a clinical study titled "Exercise in All ChemoTherapy". Exercise in all Chemotherapy (EnACT) is a study to assess safety, feasibility, and acceptability of an exercise program within chemotherapy. This will be a single group study to capture the effects of an exercise intervention on the average chemotherapy patient and the patients compliance to the stu...

What is the current status of trial NCT03461471?

This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2017-04-01. Estimated completion is 2019-03-30.

What interventions are being tested in trial NCT03461471?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03461471?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03461471's enrollment target sits among peer trials

168 619th of 2000 higher than 1,379 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03461471, the US trial registry maintained by the National Library of Medicine. NCT03461471 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.